IFNL3 and Alzheimer disease: Analysis of postmortem brain tissues, including hippocampal and temporal cortex samples, from AD patients and non-demented controls revealed that the mRNA levels of IRF7, MED23, IL28B, and IFN-α were significantly reduced in the hippocampus and temporal cortex of most AD patients [46].